Key result
Telemedicine use for HF in conflict settings reaches just ~6%, severely limited by lack of awareness.
Why the study?
Heart failure management in conflict zones faces unique logistical and clinical challenges, and the feasibility of telemedicine to sustain continuity of care in such fragile settings remains underexplored.
What are the barriers to and awareness of telemedicine use for heart failure management in armed conflict settings?
Cross-Sectional (n=190)
Yes
What are the barriers to and awareness of telemedicine use for heart failure management in armed conflict settings?
Telemedicine adoption for heart failure management in conflict-affected settings is severely limited by poor digital infrastructure, low awareness, and population displacement, highlighting the need for low-bandwidth, resilient telehealth platforms.
Poor telemedicine awareness limits adoption in acute cardiovascular care; leaves open targeted education trials to reduce disruptions.
Background Heart failure (HF) management in conflict zones presents unique logistical and clinical challenges. In regions affected by recent armed conflict, access to healthcare has been severely disrupted. While telemedicine offers potential to sustain continuity of care, its feasibility in such fragile settings remains underexplored. Purpose To assess patients’ knowledge, accessibility, and challenges in using telemedicine for HF management during an ongoing armed conflict, and to evaluate its impact on continuity of care. Methods A cross-sectional study was conducted between August 2024 and May 2025 among 190 outpatients with HF recruited from five hospitals across five regions in a country with an ongoing armed conflict. Structured, interviewer-administered questionnaires were used to assess telemedicine awareness, access barriers, and healthcare continuity. Data were analyzed using descriptive and inferential statistics with Statistical Package for the Social Science software. Results Most patients (92.1%) were on HF medications; however, 7.9% reported access challenges, primarily due to unaffordability (4.7%) and unavailability (1.6%). Telemedicine use was minimal (5.8%), and awareness was poor, with 87.2% of respondents unaware of any available telemedicine services. Major barriers included lack of internet access (21.3%), unstable electricity (13.8%), and absence of digital devices (12.2%). Conflict conditions further impeded care—28.4% of patients were internally displaced, and 21.1% reported safety concerns. Only 42.1% had recent clinical follow-up, while 14.7% had not received care for over a year. Nearly one-third (31.2%) experienced severe HF symptoms, and none were aware of their specific HF subtype. Telemedicine knowledge strongly predicted use (p < 0.001), while displacement was associated with care disruption (p = 0.032). Conclusion Telemedicine adoption for HF management in conflict-affected settings remains extremely limited, constrained by poor digital infrastructure, low awareness, and population displacement. Investment in low-bandwidth, resilient telehealth platforms and targeted education for patients and providers is urgently needed to preserve continuity of care.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2026) conducted a cross-sectional in Heart failure (n=190). Telemedicine was evaluated on Telemedicine awareness, access barriers, and healthcare continuity. Telemedicine use for heart failure in conflict settings was minimal (5.8%), with 87.2% unaware of services, while telemedicine knowledge strongly predicted use (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: